Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)

NCT04578392 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT04578392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04578392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Terminated
Start date
July 28, 2020
Completion date
December 31, 2023
Enrollment
13 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease